Pediatrix Medical Group, Inc. $MD Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH boosted its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 139.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 69,069 shares of the company’s stock after buying an additional 40,176 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.08% of Pediatrix Medical Group worth $1,493,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MD. Blue Trust Inc. acquired a new stake in Pediatrix Medical Group during the fourth quarter valued at $37,000. KBC Group NV acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at about $65,000. Canada Pension Plan Investment Board acquired a new stake in shares of Pediatrix Medical Group in the second quarter valued at about $83,000. Quantbot Technologies LP acquired a new stake in shares of Pediatrix Medical Group in the second quarter valued at about $99,000. Finally, Smartleaf Asset Management LLC grew its position in shares of Pediatrix Medical Group by 10.6% in the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock valued at $101,000 after purchasing an additional 601 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Price Performance

Shares of MD stock opened at $22.72 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.66. The firm’s 50-day moving average is $20.96 and its two-hundred day moving average is $21.18. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $24.99. The company has a market capitalization of $1.89 billion, a PE ratio of 11.71 and a beta of 0.70.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Thursday, February 19th. The company reported $0.50 EPS for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.The firm had revenue of $493.77 million for the quarter, compared to analysts’ expectations of $486.23 million. During the same period last year, the firm earned $0.51 earnings per share. Pediatrix Medical Group’s revenue for the quarter was down 1.7% on a year-over-year basis. Analysts predict that Pediatrix Medical Group, Inc. will post 2.05 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. UBS Group dropped their target price on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 24th. Zacks Research lowered shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 23rd. Truist Financial lifted their target price on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, April 13th. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 target price on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $21.33.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.